IMPLEMENTATION OF SUBLINGUAL KETAMINE IN TREATMENT-RESISTANT DEPRESSION (TRD): A SYNTHESIS OF AVAILABLE EVIDENCE

被引：0
|
作者：
Rao, R. R. [1 ,2 ]
Hall, S. [1 ,2 ]
机构：
[1] Healthscope, Geelong Clin, St Albans Pk, Vic, Australia
[2] Barwon Hlth, Geelong, Vic, Australia
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2023年 / 57卷 / 01期
关键词：
ANTIDEPRESSANT; ESKETAMINE; EFFICACY;
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：190 / 191
页数：2
相关论文
共 50 条
  • [31] Modulating neuroplasticity through synergistic ketamine and accelerated sequential theta burst stimulation (TBS) for treatment-resistant depression (TRD) - A case report
    Ramesh, Veena
    Shamanna, Varsha
    Pathak, Harsh
    Nayok, Swarna Buddha
    Bose, Anushree
    Sreeraj, Vanteemar S.
    ASIAN JOURNAL OF PSYCHIATRY, 2024, 102
  • [32] Esketamine for treatment-resistant depression: A review of clinical evidence (Review)
    Vasiliu, Octavian
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 25 (03)
  • [33] Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression
    Acevedo-Diaz, Elia E.
    Cavanaugh, Grace W.
    Greenstein, Dede
    Kraus, Christoph
    Kadriu, Bashkim
    Zarate, Carlos A.
    Park, Lawrence T.
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 263 : 568 - 575
  • [34] Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report
    Joseph, Boney
    Nunez, Nicolas A.
    Kung, Simon
    Voort, Jennifer L. Vande
    Pazdernik, Vanessa K.
    Schak, Kathryn M.
    Boehm, Stacey M.
    Carpenter, Brooke
    Johnson, Emily K.
    Malyshev, Grigoriy
    Smits, Nathan
    Adewunmi, Daniel O.
    Brown, Sarah K.
    Singh, Balwinder
    PHARMACEUTICALS, 2023, 16 (08)
  • [35] A comparison of the safety, feasibility, and tolerability of ECT and ketamine for treatment-resistant depression
    Tamman, Amanda
    Anand, Amit
    Mathew, Sanjay J.
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (06) : 745 - 759
  • [36] Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
    Eric P. McMullen
    Yena Lee
    Orly Lipsitz
    Leanna M. W. Lui
    Maj Vinberg
    Roger Ho
    Nelson B. Rodrigues
    Joshua D. Rosenblat
    Bing Cao
    Hartej Gill
    Kayla M. Teopiz
    Danielle S. Cha
    Roger S. McIntyre
    Advances in Therapy, 2021, 38 : 2795 - 2820
  • [37] Repeated subcutaneous racemic ketamine in treatment-resistant depression: case series
    Tham, Joseph C. W.
    Do, Andre
    Fridfinnson, Jason
    Rafizadeh, Reza
    Siu, Jacky T. P.
    Budd, George P.
    Lam, Raymond W.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2022, 37 (05) : 206 - 214
  • [38] Understanding the variability in ketamine's efficacy in managing treatment-resistant depression
    Bryan, Joshua W.
    DISCOVER PSYCHOLOGY, 2024, 4 (01):
  • [39] A Pain Physician and Anesthesiologist’s Perspective on Ketamine for Treatment-Resistant Depression
    Lauren E. Gatewood
    Andrew W. Gorlin
    Christopher H. Bailey
    George Barsoum
    Steven B. Porter
    SN Comprehensive Clinical Medicine, 5 (1)
  • [40] Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of Excellence
    Di Vincenzo, Joshua D.
    Lipsitz, Orly
    Rodrigues, Nelson B.
    Lee, Yena
    Gill, Hartej
    Kratiuk, Kevin
    Subramaniapillai, Mehala
    Mansur, Rodrigo
    McIntyre, Roger S.
    Rosenblat, Joshua D.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2021, 143 : 209 - 214
12345